tiprankstipranks
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID
Want to see OVID full AI Analyst Report?

Compare Ovid Therapeutics (OVID) vs. Competitors

1,756 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Ovid Therapeutics
$2.91
$484.50M
3.44
852.38%
8 Buy
0 Hold
0 Sell
Strong Buy
Opus Genetics
$5.75
$356.30M
-18.92
401.51%
12 Buy
0 Hold
0 Sell
Strong Buy
Zentalis Pharmaceuticals
$1.41
$312.81M
-0.69
250.00%
4 Buy
1 Hold
0 Sell
Strong Buy
Inhibikase Therapeutics
$1.83
$271.99M
-3.96
-1.90%
5 Buy
0 Hold
0 Sell
Strong Buy
Surrozen
$31.56
$336.24M
-0.63
233.29%
5 Buy
0 Hold
0 Sell
Strong Buy
Biomea Fusion
$2.21
$111.34M
4.86
-12.00%
5 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OVID
Ovid Therapeutics
2.80
2.50
827.15%
IRD
Opus Genetics
4.99
4.04
425.26%
ZNTL
Zentalis Pharmaceuticals
4.41
3.12
241.86%
IKT
Inhibikase Therapeutics
2.06
-0.13
-5.94%
SRZN
Surrozen
28.96
20.96
262.00%
BMEA
Biomea Fusion
1.54
-0.23
-12.99%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts